نتائج البحث 461-470 من 2260 لعملية البحث عن anti-TNF drugs
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...
This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...
for treatment of acute procedural pain in patients receiving onabotulinumtoxinA for the treatment of chronic migraine. A Study of Multicenter Outcomes in ...
... therapy can predict pathological Complete Response (pCR). ... Drugs used in chemotherapy, such as cisplatin ... The purpose of this study is to evaluate the safety, ...
However, the use of anti-inflammatory agents in ... Diet rich in trans-fat and sugar has been shown to increase pro-inflammatory cytokines IL-6 and TNFα ...
الورم النقوي المتعدِّد المنتكس والمقاوم للعلاج; أنواع السرطان الأخرى والحالات الطبية التي تخضع للدراسات السريرية. إذا كنت مؤهلاً لعلاج مستقبلات المستضد الخيمرية ...
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...
Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...
... Treatment. Rochester, Minn. The purposes of this study are to determine the levels of prostate cancer-derived extracellular vesicles pre- and post-local therapy ...
The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.